Celldex Therapeutics Competitors and Similar CompaniesClear all
Deciphera Pharmaceuticals's competitors and similar companies include Marker Therapeutics.
 Deciphera Pharmaceuticals Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer. |  Marker Therapeutics Marker Therapeutics is a biopharmaceutical company engaged in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection. | |
Founding Date | Founding Date 2003 | Founding Date 2018 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Waltham, US HQ Lawrence, US | Locations Houston, US HQ |
Employees | Employees 35037% increase | Employees 888% decrease |
Valuation ($) | Valuation ($) 2.2 b | Valuation ($) 36.5 m |
Financial | ||
Revenue (est.) | Revenue (est.) $163.4m (FY, 2023) | Revenue (est.) $3.5m (FY, 2025) |
Net income | Net income ($194.9m) (FY, 2023) | Net income ($12.2m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Marker Therapeutics
HQ
Houston, US
Employees
8
Marker Therapeutics is a biopharmaceutical company engaged in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection.
View company